Peroxiredoxin I is a ROS/p38 MAPK-dependent inducible antioxidant that regulates NF-κB-mediated iNOS induction and microglial activation

Abbas, 2009, Signaling events leading to peroxiredoxin 5 up-regulation in immunostimulated macrophages, Free Radic. Biol. Med., 47, 794, 10.1016/j.freeradbiomed.2009.06.018

Acharya, 2010, Redox regulation in cancer: a double-edged sword with therapeutic potential, Oxidative Med. Cell. Longev., 3, 23, 10.4161/oxim.3.1.10095

Basso, 2004, Proteome analysis of human substantia nigra in Parkinson's disease, Proteomics, 4, 3943, 10.1002/pmic.200400848

Bonda, 2010, Oxidative stress in Alzheimer disease: a possibility for prevention, Neuropharmacology, 59, 290, 10.1016/j.neuropharm.2010.04.005

Calabrese, 2007, Redox regulation of cellular stress response in aging and neurodegenerative disorders: role of vitagenes, Neurochem. Res., 32, 757, 10.1007/s11064-006-9203-y

Chen, 2005, Inhibition of iNOS gene expression by quercetin is mediated by the inhibition of IkappaB kinase, nuclear factor-kappa B and STAT1, and depends on heme oxygenase-1 induction in mouse BV-2 microglia, Eur. J. Pharmacol., 521, 9, 10.1016/j.ejphar.2005.08.005

Chiche, 1998, Adenovirus-mediated gene transfer of cGMP-dependent protein kinase increases the sensitivity of cultured vascular smooth muscle cells to the antiproliferative and pro-apoptotic effects of nitric oxide/cGMP, J. Biol. Chem., 273, 34263, 10.1074/jbc.273.51.34263

Chowdhury, 2009, Corn extracts lower tissue arsenic level in rat, Bangladesh Med. Res. Counc. Bull., 35, 21, 10.3329/bmrcb.v35i1.2533

Coyle, 1993, Oxidative stress, glutamate, and neurodegenerative disorders, Science, 262, 689, 10.1126/science.7901908

Diet, 2007, Regulation of peroxiredoxins by nitric oxide in immunostimulated macrophages, J. Biol. Chem., 282, 36199, 10.1074/jbc.M706420200

Domingues, 2008, Mitochondria and ubiquitin-proteasomal system interplay: relevance to Parkinson's disease, Free Radic. Biol. Med., 45, 820, 10.1016/j.freeradbiomed.2008.06.007

Dumont, 2011, Neuroprotective strategies involving ROS in Alzheimer disease, Free Radic. Biol. Med., 51, 1014, 10.1016/j.freeradbiomed.2010.11.026

Gloire, 2006, NF-kappaB activation by reactive oxygen species: fifteen years later, Biochem. Pharmacol., 72, 1493, 10.1016/j.bcp.2006.04.011

Himadri, 2010, Role of oxidative stress and inflammation in hypoxia-induced cerebral edema: a molecular approach, High Alt Med. Biol., 11, 231, 10.1089/ham.2009.1057

Huang, 2004, Redox-active metals, oxidative stress, and Alzheimer's disease pathology, Ann. N. Y. Acad. Sci., 1012, 153, 10.1196/annals.1306.012

Hurd, 2012, Redox regulation of cell migration and adhesion, Trends Cell Biol., 22, 107, 10.1016/j.tcb.2011.11.002

Ikegaya, 1999, Abnormal targeting of developing hippocampal mossy fibers after epileptiform activities via l-type Ca2+ channel activation in vitro, J. Neurosci., 19, 802, 10.1523/JNEUROSCI.19-02-00802.1999

Ishii, 2000, Subacute NO generation induced by Alzheimer's beta-amyloid in the living brain: reversal by inhibition of the inducible NO synthase, FASEB J., 14, 1485

Ishii, 2012, Novel roles of peroxiredoxins in inflammation, cancer and innate immunity, J. Clin. Biochem. Nutr., 50, 91, 10.3164/jcbn.11-109

Ishii, 1993, Cloning and characterization of a 23-kDa stress-induced mouse peritoneal macrophage protein, J. Biol. Chem., 268, 18633, 10.1016/S0021-9258(17)46676-2

Jeong, 2004, Modulatory properties of various natural chemopreventive agents on the activation of NF-kappaB signaling pathway, Pharm. Res., 21, 661, 10.1023/B:PHAM.0000022413.43212.cf

Jin, 2005, Characterization of neural cell types expressing peroxiredoxins in mouse brain, Neurosci. Lett., 381, 252, 10.1016/j.neulet.2005.02.048

Jurgens, 2012, Dysregulated neuronal-microglial cross-talk during aging, stress and inflammation, Exp. Neurol., 233, 40, 10.1016/j.expneurol.2010.11.014

Kim, 2002, Neuroprotective effects of prostaglandin E2 or cAMP against microglial and neuronal free radical mediated toxicity associated with inflammation, J. Neurosci. Res., 70, 97, 10.1002/jnr.10373

Kim, 2001, Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer's disease and Down syndrome, J. Neural Transm., 223

Kim, 2008, Peroxiredoxin I is an indicator of microglia activation and protects against hydrogen peroxide-mediated microglial death, Biol. Pharm. Bull., 31, 820, 10.1248/bpb.31.820

Kim, 2011, Peroxiredoxin II preserves cognitive function against age-linked hippocampal oxidative damage, Neurobiol. Aging, 32, 1054, 10.1016/j.neurobiolaging.2009.05.017

Kim, 2007, Human prx1 gene is a target of Nrf2 and is up-regulated by hypoxia/reoxygenation: implication to tumor biology, Cancer Res., 67, 546, 10.1158/0008-5472.CAN-06-2401

Krapfenbauer, 2003, Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders, Brain Res., 967, 152, 10.1016/S0006-8993(02)04243-9

Krapfenbauer, 2002, Expression patterns of antioxidant proteins in brains of patients with sporadic Creutzfeldt–Jakob disease, Electrophoresis, 23, 2541, 10.1002/1522-2683(200208)23:15<2541::AID-ELPS2541>3.0.CO;2-1

Lee, 2011, Peroxiredoxin I regulates the component expression of gamma-secretase complex causing the Alzheimer's disease, Lab. Anim. Res., 27, 293, 10.5625/lar.2011.27.4.293

Li, 2002, NF-kappaB regulation in the immune system, Nat. Rev. Immunol., 2, 725, 10.1038/nri910

Lund, 2006, The dynamics of the LPS triggered inflammatory response of murine microglia under different culture and in vivo conditions, J. Neuroimmunol., 180, 71, 10.1016/j.jneuroim.2006.07.007

Melo, 2011, Oxidative stress in neurodegenerative diseases: mechanisms and therapeutic perspectives, Oxidative Med. Cell. Longev., 2011, 467180, 10.1155/2011/467180

Nakano, 2006, Reactive oxygen species mediate crosstalk between NF-kappaB and JNK, Cell Death Differ., 13, 730, 10.1038/sj.cdd.4401830

Olson, 2004, Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs, J. Immunol., 173, 3916, 10.4049/jimmunol.173.6.3916

Pawate, 2004, Redox regulation of glial inflammatory response to lipopolysaccharide and interferongamma, J. Neurosci. Res., 77, 540, 10.1002/jnr.20180

Park, 2013, Prx I suppresses K-ras-driven lung tumorigenesis by opposing redox-sensitive ERK/cyclin D1 pathway, Antioxid. Redox Signal., 10.1089/ars.2011.4421

Peng, 2005, Pivotal role of gp91phox-containing NADH oxidase in lipopolysaccharide-induced tumor necrosis factor-alpha expression and myocardial depression, Circulation, 111, 1637, 10.1161/01.CIR.0000160366.50210.E9

Peristeris, 1992, N-acetylcysteine and glutathione as inhibitors of tumor necrosis factor production, Cell. Immunol., 140, 390, 10.1016/0008-8749(92)90205-4

Rohl, 2010, Mechanisms involved in the modulation of astroglial resistance to oxidative stress induced by activated microglia: antioxidative systems, peroxide elimination, radical generation, lipid peroxidation, Neurotox. Res., 17, 317, 10.1007/s12640-009-9108-z

Sun, 2010, Microglial peroxiredoxin V acts as an inducible anti-inflammatory antioxidant through cooperation with redox signaling cascades, J. Neurochem., 114, 39, 10.1111/j.1471-4159.2010.06691.x

Sun, 2008, Substance P enhances NF-kappaB transactivation and chemokine response in murine macrophages via ERK1/2 and p38 MAPK signaling pathways, Am. J. Physiol. Cell Physiol., 294, C1586, 10.1152/ajpcell.00129.2008

Tae Lim, 2012, Peroxiredoxin-1, a possible target in modulating inflammatory cytokine production in macrophage like cell line RAW264.7, Microbiol. Immunol., 56, 411, 10.1111/j.1348-0421.2012.00453.x

Takahashi, 2012, Oxidative stress and redox regulation on in vitro development of mammalian embryos, J. Reprod. Dev., 58, 1, 10.1262/jrd.11-138N

Torres, 2003, Mitogen-activated protein kinase pathways in redox signaling, Front. Biosci., 8, d369, 10.2741/999

Torres, 2003, Redox signaling and the MAP kinase pathways, Biofactors, 17, 287, 10.1002/biof.5520170128

Watters, 2002, A differential role for the mitogen-activated protein kinases in lipopolysaccharide signaling: the MEK/ERK pathway is not essential for nitric oxide and interleukin 1beta production, J. Biol. Chem., 277, 9077, 10.1074/jbc.M104385200

Weber, 1994, Antioxidative effect of dietary coenzyme Q10 in human blood plasma, Int. J. Vitam. Nutr. Res., 64, 311

Wiser, 2008, In vivo gamma-tocopherol supplementation decreases systemic oxidative stress and cytokine responses of human monocytes in normal and asthmatic subjects, Free Radic. Biol. Med., 45, 40, 10.1016/j.freeradbiomed.2008.03.002

Xu, 2005, Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells, Oncogene, 24, 4486, 10.1038/sj.onc.1208656

Zhang, 2011, Redox control of the survival of healthy and diseased cells, Antioxid. Redox. Signal., 15, 2867, 10.1089/ars.2010.3685

Zhang, 2005, MAP kinases in immune responses, Cell. Mol. Immunol., 2, 20

Zhu, 2012, The antioxidant enzyme peroxiredoxin and its protective role in neurological disorders, Exp. Biol. Med., 237, 143, 10.1258/ebm.2011.011152

Zhu, 1999, Characterization of replication-competent adenovirus isolates from large-scale production of a recombinant adenoviral vector, Hum. Gene. Ther., 10, 113, 10.1089/10430349950019246